Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-192.29%Return on Equity
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.76 - $ 10.48 52-Week Range
Ticker Information
Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMUNE BIO INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INMB - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 28.87M | $ -55.51M | -192.29% |
| 3/31/2025 | $ 29.67M | $ -40.8M | -137.49% |
| 12/31/2024 | $ 32.1M | $ -42.08M | -131.11% |
| 9/30/2024 | $ 38.67M | $ -41.27M | -106.71% |
| 6/30/2024 | $ 36.28M | $ -37.74M | -104.03% |
| 3/31/2024 | $ 28.22M | $ -34.5M | -122.23% |
| 12/31/2023 | $ 37.34M | $ -30.01M | -80.36% |
| 9/30/2023 | $ 43.93M | $ -27.43M | -62.44% |
| 6/30/2023 | $ 50.65M | $ -26.59M | -52.5% |
| 3/31/2023 | $ 55.3M | $ -26.93M | -48.71% |
Key Performance Insights, Last 5 Years
- INMUNE BIO INC's latest trailing twelve months (TTM) ROE stands at -27.21%.
- Over the past 5 years, INMUNE BIO INC's average ROE has been -70.64%.
- The median ROE for INMUNE BIO INC during this period was -48.79%
- INMUNE BIO INC reached its highest ROE over the past 5 years at -22.95%.
- The lowest ROE recorded by INMUNE BIO INC in the same timeframe -192.29%
INMUNE BIO INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for INMUNE BIO INC is calculated as follows: Net Inc. Cmn. [ $ -11.21M ] / Equity [ $ 41.21M ]
(=) ROE [ -27.21% ] INMB - Return on Equity, Last 5 years
-192.29%
Minimum
Jun 30, 2025
-22.95%
Maximum
Mar 31, 2021
-70.64%
Average
-48.79%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |